rewirebio.iobenchmarks
Dataset

BRCA2 functional reference calibration set

Functionally unaffected and fully affected substitutions inside clinically important domains; assumed benign/pathogenic labels are functional proxies, not independent complete clinical classifications.

Evaluation results

2 evaluations · 17 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA2 generic BayesDel threshold evidence-code assignment
Dataset: BRCA2 functional reference calibration set
<10% Proportion (benign reference variants assigned BP4)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, BP4 code would be assigned to <10% of BRCA1 and BRCA2 benign reference variants
Configuration: BayesDel generic Pejaver evidence thresholds in ENIGMA comparisonProtocol: BRCA2 generic BayesDel threshold evidence-code assignment
Dataset: BRCA2 functional reference calibration set
36% Proportion (benign reference variants assigned PP3)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 generic BayesDel threshold comparator

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Results, BayesDel calibration, sentence 29% for BRCA1 and 36% for BRCA2 incorrectly assigned PP3
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
29 Count (interval: high, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, benign_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
10% Proportion (interval: high, benign)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, benign_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
6.59 Likelihood ratio (interval: high)
unitless · unknown

Uncertainty: 95% CI 4.40 to 9.90

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, likelihood_ratio
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
88 Count (interval: high, pathogenic)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, pathogenic_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
66% Proportion (interval: high, pathogenic)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≥0.30, pathogenic_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
216 Count (interval: low, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, benign_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
74% Proportion (interval: low, benign)
percent · higher

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, benign_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
0.21 Likelihood ratio (interval: low)
unitless · unknown

Uncertainty: 95% CI 0.14 to 0.33

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, likelihood_ratio
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
21 Count (interval: low, pathogenic)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, pathogenic_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
16% Proportion (interval: low, pathogenic)
percent · lower

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel ≤0.18, pathogenic_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
46 Count (interval: middle, benign)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, benign_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
16% Proportion (interval: middle, benign)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, benign_fraction
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
1.18 Likelihood ratio (interval: middle)
unitless · unknown

Uncertainty: 95% CI 0.73 to 1.90

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, likelihood_ratio
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
25 Count (interval: middle, pathogenic)
count · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, pathogenic_count
Configuration: BayesDel with ENIGMA BRCA gene-specific score categoriesProtocol: BRCA2 BayesDel evidence calibration
Dataset: BRCA2 functional reference calibration set
19% Proportion (interval: middle, pathogenic)
percent · unknown

Uncertainty: Not reported by the source: not reported for this endpoint

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

BRCA2 BayesDel gene-specific calibration

Not reported

Aggregation: Not reported

Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel · Table 2, BRCA2, BayesDel >0.18 and <0.30, pathogenic_fraction

Source checking is not independent reproduction. Release 2026-11-21-adc15377fab2.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-adc15377fab2 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

5 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-adc15377fab2
Property and statementOriginal source and locationReview and provenance
Benign reference count
291
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Table 2 footnote a; Table S3 referenced but unavailable in retrieval

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.benign_reference_count

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Pathogenic reference count
134
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Table 2 footnote a; Table S3 referenced but unavailable in retrieval

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.pathogenic_reference_count

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Source location
Table 2 footnote a; Table S3 referenced but unavailable in retrieval
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Table 2 footnote a; Table S3 referenced but unavailable in retrieval

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Functionally unaffected and fully affected substitutions inside clinically important domains; assumed benign/pathogenic labels are functional proxies, not independent complete clinical classifications.
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Table 2 footnote a; Table S3 referenced but unavailable in retrieval

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Name
BRCA2 functional reference calibration set
Context-only references
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel

Original source ↗

Table 2 footnote a; Table S3 referenced but unavailable in retrieval

Version: 2024 final article; reported VCEP specifications v1.0
Retrieved: 2026-09-30T21:24:15Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 21e7b0792e18a1295b7bccb8b19ebe4432a2b047187139407c8616ea0cd531f2

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-11-21-adc15377fab2 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID uc-clinical-20260930-enigma-brca2-data.

Source locator: Table 2 footnote a; Table S3 referenced but unavailable in retrieval

Related records

Suggest a correction